🔎 Trials Near Me

Home › Hearing Loss › NCT07222202

Evaluation of Flexible Conductive Hearing Aids

RecruitingHealthy volunteers welcome

A Noninvasive, Flexible Conductive Hearing Aid With Micro-epidermal Actuators on Pediatric and Adult Patients

Who can join

6 Months – 80 Years · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Male and female infants, children, adolescents, and adult patients who are diagnosed with unilateral or bilateral mixed or conductive hearing loss
* Male and female patients seen at Atrium Health-Audiology for a clinical, standard of care office visit who have a diagnosis of conductive or mixed hearing loss and may currently wear hearing aids
* Male and female infants, children, adolescents, and adults who are candidates for conductive hearing aids (Osseo-integrated or wearable aids) or for canalplasty or ossicular chain reconstruction surgery
* Healthy subjects will include male and female infants, children, adolescents, and adults who do not have conductive or mixed hearing loss
* Pregnant women -are eligible for this study. Standard of Care allows pregnant patients to be fit for hearing aids without risk.

Exclusion Criteria:

* Adult patients unable to independently understand the purpose of the study and the procedures and/or who are not willing to participate

About the study

Conductive hearing loss (CHL) is the most common type of hearing loss among the pediatric population. CHL occurs when sound is not properly transmitted from the external ear to the cochlea, and congenital pathologies like microtia/anotia, atresia, and absent or malformed ossicles make hearing loss permanent.

What is being tested

Sponsor: Wake Forest University Health Sciences · Participants: 200 · Started: Jan 14, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07222202

Locations in the U.S.

North CarolinaWake Forest University Health Sciences, Winston-Salem

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.